[PDF][PDF] Final results of a double‐blind, placebo‐controlled trial of the antifibrotic efficacy of interferon‐γ1b in chronic hepatitis C patients with advanced fibrosis or …
Abstract Interferon‐γ1b (IFN‐γ1b) is a pleiotropic cytokine that displays antifibrotic, antiviral,
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
PJ Pockros, L Jeffers, N Afdhal, ZD Goodman… - 2007 - cabidigitallibrary.org
Abstract Interferon-γ1b (IFN-γ1b) is a pleiotropic cytokine that displays antifibrotic, antiviral,
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
[引用][C] Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gammalb in chronic hepatitis C patients with advanced fibrosis or …
P PJ - Hepatology, 2007 - cir.nii.ac.jp
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gammalb
in chronic hepatitis C patients with advanced fibrosis or cirrhosis | CiNii Research CiNii 国立 …
in chronic hepatitis C patients with advanced fibrosis or cirrhosis | CiNii Research CiNii 国立 …
[引用][C] Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or …
PJ POCKROS, L JELLERS, LM BLATT… - Hepatology …, 2007 - scholarship.miami.edu
Abstract Gastroenterology. Liver. Pancreas. Abdomen Viral hepatitis Infectious diseases
Liver. Biliary tract. Portal circulation. Exocrine pancreas Viral diseases Biological and …
Liver. Biliary tract. Portal circulation. Exocrine pancreas Viral diseases Biological and …
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis
PJ Pockros, L Jeffers, N Afdhal, ZD Goodman… - Hepatology, 2007 - journals.lww.com
Abstract Interferon-γ1b (IFN-γ1b) is a pleiotropic cytokine that displays antifibrotic, antiviral,
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
and antiproliferative activity. A total of 502 patients with compensated liver disease and an …
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or …
PJ Pockros, L Jeffers, N Afdhal… - Hepatology …, 2007 - europepmc.org
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b
in chronic hepatitis C patients with advanced fibrosis or cirrhosis. - Abstract - Europe PMC Sign …
in chronic hepatitis C patients with advanced fibrosis or cirrhosis. - Abstract - Europe PMC Sign …
[引用][C] Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or …
PJ POCKROS, L JELLERS, LM BLATT… - Hepatology …, 2007 - pascal-francis.inist.fr
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b
in chronic hepatitis C patients with advanced fibrosis or cirrhosis CNRS Inist Pascal-Francis …
in chronic hepatitis C patients with advanced fibrosis or cirrhosis CNRS Inist Pascal-Francis …
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or …
PJ Pockros, L Jeffers, N Afdhal, ZD Goodman… - 2007 - pubmed.ncbi.nlm.nih.gov
Interferon-gamma1b (IFN-gamma1b) is a pleiotropic cytokine that displays antifibrotic,
antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease …
antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease …
[引用][C] Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or …
PJ Pockros, L Jeffers, N Afdhal, ZD Goodman… - Hepatology, 2007 - cir.nii.ac.jp
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b
in chronic hepatitis C patients with advanced fibrosis or cirrhosis | CiNii Research CiNii 国立 …
in chronic hepatitis C patients with advanced fibrosis or cirrhosis | CiNii Research CiNii 国立 …